Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma.
Turan N, Benekli M, Unal OU, Unek İT, Tastekin D, Dane F, Algın E, Ulger S, Eren T, Topcu TO, Turkmen E, Babacan NA, Tufan G, Urakci Z, Ustaalioglu BO, Uysal OS, Ercelep OB, Taskoylu BY, Aksoy A, Canhoroz M, Demirci U, Dogan E, Berk V, Balakan O, Ekinci AŞ, Uysal M, Petekkaya İ, Ozturk SC, Tonyalı Ö, Çetin B, Aldemir MN, Helvacı K, Ozdemir N, Oztop İ, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Turan N, et al. Among authors: ercelep ob. Chin J Cancer Res. 2015 Aug;27(4):408-16. doi: 10.3978/j.issn.1000-9604.2015.08.03. Chin J Cancer Res. 2015. PMID: 26361410 Free PMC article.
Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology.
Ozcelik M, Seker M, Eraslan E, Koca S, Yazilitas D, Ercelep O, Ozaslan E, Kaya S, Hacibekiroglu I, Menekse S, Aksoy A, Taskoylu BY, Varol U, Arpaci E, Ciltas A, Oksuzoglu B, Zengin N, Gumus M, Aliustaoglu M. Ozcelik M, et al. Among authors: ercelep o. Tumour Biol. 2016 Apr;37(4):5231-7. doi: 10.1007/s13277-015-4359-1. Epub 2015 Nov 10. Tumour Biol. 2016. PMID: 26553363
Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer.
Dinc NS, Aydın K, Odabas H, Ercelep O, Tufan G, Seker M, Yasar N, Aydin D, Yuksel S, Mert A, Ozcelik M, Korkmaz T, Yildiz R, Aliustaoglu M, Mayadagli A, Dane F, Gumus M. Dinc NS, et al. Among authors: ercelep o. Oncol Res Treat. 2016;39(3):130-4. doi: 10.1159/000444272. Epub 2016 Feb 23. Oncol Res Treat. 2016. PMID: 27030981
Chordoma: a case series and review of the literature.
Alan O, Akin Telli T, Ercelep O, Tanrikulu Simsek E, Basoglu Tuylu T, Mutis A, Hasanov R, Kaya S, Akgül Babacan N, Dane F, Yumuk PF. Alan O, et al. Among authors: ercelep o. J Med Case Rep. 2018 Aug 27;12(1):239. doi: 10.1186/s13256-018-1784-y. J Med Case Rep. 2018. PMID: 30145982 Free PMC article. Review.
A rare case of primary rectal choriocarcinoma and review of the literature.
Telli TA, Demircan NC, Alan O, Tuylu TB, Arikan R, Ercelep O, Atıcı AE, Ergelen R, Seven IE, Babacan NA, Kaya S, Dane F, Fulden Yumuk P. Telli TA, et al. Among authors: ercelep o. J Oncol Pharm Pract. 2020 Jun;26(4):989-994. doi: 10.1177/1078155219875510. Epub 2019 Sep 23. J Oncol Pharm Pract. 2020. PMID: 31547751 Review.
How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
Alan O, Kuzhan O, Koca S, Telli TA, Basoglu T, Ercelep O, Filinte D, Sengul Y, Arikan H, Kaya S, Babacan NA, Dane F, Yumuk PF. Alan O, et al. Among authors: ercelep o. J Oncol Pharm Pract. 2020 Jun;26(4):1011-1018. doi: 10.1177/1078155219879757. Epub 2019 Oct 15. J Oncol Pharm Pract. 2020. PMID: 31615346 Review.
52 results